Phibro Animal Health Corporation (PAHC) to Issue Quarterly Dividend of $0.12 on March 25th

Phibro Animal Health Corporation (NASDAQ:PAHC) announced a quarterly dividend on Tuesday, February 3rd. Investors of record on Wednesday, March 4th will be given a dividend of 0.12 per share on Wednesday, March 25th. This represents a c) annualized dividend and a yield of 0.9%. The ex-dividend date is Wednesday, March 4th.

Phibro Animal Health has a payout ratio of 23.9% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Phibro Animal Health to earn $2.10 per share next year, which means the company should continue to be able to cover its $0.48 annual dividend with an expected future payout ratio of 22.9%.

Phibro Animal Health Trading Down 0.2%

Shares of NASDAQ:PAHC opened at $54.59 on Monday. The company has a current ratio of 3.05, a quick ratio of 1.22 and a debt-to-equity ratio of 2.14. Phibro Animal Health has a 12-month low of $16.16 and a 12-month high of $56.30. The business has a 50 day moving average of $43.76 and a two-hundred day moving average of $40.99. The company has a market capitalization of $2.21 billion, a PE ratio of 24.26, a PEG ratio of 0.84 and a beta of 0.80.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $0.87 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.18. Phibro Animal Health had a net margin of 6.29% and a return on equity of 38.28%. The business had revenue of $373.91 million for the quarter, compared to analysts’ expectations of $355.64 million. Phibro Animal Health has set its FY 2026 guidance at 2.930-3.100 EPS. As a group, analysts forecast that Phibro Animal Health will post 1.95 EPS for the current year.

About Phibro Animal Health

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.